and are prescribed to obtain one of the following major effects: decrease of sleep latency, reduction of anxiety, suppression of epileptic seizures or relaxation of muscle spasms (Box 1). BDZs can also induce anterograde amnesia, which can be considered as an adverse side-effect at times, but loss of memory for unpleasant events could also be a useful effect, for example during invasive medical procedures (Box 1). In general, BDZs are safe and effective for short-term treatment; however, long-term use is controversial due to the development of tolerance (see Glossary) and their liability for physical dependence [4] . The Drug Abuse Warning Network, which monitors prescription and illicit drug use, found that two of the most frequently reported prescription medications in drug abuse-related cases are opioid-based pain relievers and BDZs (http://www.nida.nih.gov). Furthermore, BDZ abuse often occurs in conjunction with the abuse of another substance (e.g. alcohol or cocaine), making treatment approaches even more difficult. The knowledge of how BDZs induce addiction might help in the development of anxiolytics and hypnotics with lower addictive liability.
All addictive drugs, as well as natural rewards, increase dopamine (DA) levels in the mesolimbic dopamine (DA) system, also termed the reward system (Box 2). Several landmark studies with monkeys have shown that DA neurons play a role in signaling 'reward error prediction', and thus are involved in learning processes related to reward and intrinsic value. Specifically, DA neurons are excited following the presentation of an unexpected reward. Once this reward becomes predictable (by an experimentally controlled cue), DA neurons shift their phasic activation from the reward to the cue. Finally, when the cue is present but the reward is withheld, DA neurons are inhibited [5, 6] . Unlike natural rewards, addictive drugs always cause an increase in DA levels upon drug exposure
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Glossary AMPA/NMDA ratio: ratio of the amplitudes of EPSCs mediated by AMPARs and NMDARs, respectively. An increase in the AMPA/NMDA ratio could be due to enhanced AMPAR transmission, reduced NMDAR transmission, or a concomitant change in both components. Changes in the AMPA/NMDA ratio are considered to be a hallmark of synaptic plasticity. Deactivation of receptor: the process by which activated receptors relax toward the resting state. Desensitization of receptor: the decay in receptor efficacy produced in the continuous presence of an agonist. Dependence: an adaptive state induced by chronic drug use that becomes apparent when abrupt cessation of drug use induces a withdrawal syndrome, which is typically preceded by tolerance. Drug addiction: a chronic disorder characterized by compulsive drug-seeking and drug-taking behavior that persists despite negative consequences. I/V curve: current/voltage relationship that is determined by plotting the EPSC amplitude as a function of the membrane potential. For AMPAR-mediated EPSCs in VTA DA neurons, the I/V curve is linear and reverses at 0 mV in slices from naïve or saline injected mice. After administration of an addictive drug, the I/V curve is inwardly rectifying (i.e. currents at positive potential are smaller than currents recorded at mirrored negative potential). Inward rectification is the biophysical signature of GluA2-lacking AMPARs and is also considered to be a hallmark of synaptic plasticity. Progressive-ratio test: a refinement of the self-administration paradigm (below) in which particularly reinforcing substances are tested using a progressive-ratio scheme. The animal has to press the lever several times to receive one dose. During the test the ratio between lever presses and drug injection is gradually increased until the animal stops pressing the leverwhich is defined as the breakpoint. Self-administration: a behavioral paradigm used to evaluate the reinforcing properties of a substance. Animals learn to press a lever to obtain an injection of a drug. The number of lever presses is taken to quantify the reinforcement of the substance. Tolerance: reduction in the response to the drug upon repeated administration. A progressive increase in drug dosage is therefore necessary to experience the desired effects. Corresponding author: Lü scher, C. (Christian.Luscher@unige.ch).
